All stock lists
OSR Health, Inc. (OSRH)
United States · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.14+$0.04 (+40.00%)
Insider Score
––Not scored
OSRH Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
OSRH Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $315.67 K | $484.06 K | $381.27 K | $627.75 K | $1.14 M | — |
| Revenue Growth (YoY) | -72.20 % | — | — | — | — | — |
| Cost of Revenue | $229.06 K | $323.78 K | $251.56 K | $366.01 K | $1.10 M | — |
| Gross Profit | $86.61 K | $160.28 K | $129.70 K | $261.73 K | $32.78 K | — |
| SG&A Expense | $3.12 M | $1.27 M | $3.98 M | $4.07 M | $5.26 M | — |
| R&D Expense | — | $113.15 K | $176.57 K | — | — | $90.15 K |
| Operating Expenses | $3.12 M | $3.83 M | $6.52 M | $4.07 M | $5.26 M | — |
| Operating Income | -$3.03 M | -$3.67 M | -$6.39 M | -$3.80 M | -$5.23 M | — |
| Pretax Income | -$1.44 M | -$3.92 M | -$7.78 M | -$4.49 M | -$5.23 M | — |
| Tax Provision | -$439.50 K | -$452.31 K | -$534.87 K | -$1.29 M | $0.00 | — |
| Net Income | -$848.90 K | -$2.93 M | -$4.82 M | -$2.13 M | $331.41 K | — |
| EPS (Basic) | -$0.02 | -$0.09 | — | -$0.10 | $0.02 | -$1.04 |
| EPS (Diluted) | -$0.02 | -$0.09 | — | -$0.10 | $0.02 | -$1.04 |
| Shares Outstanding | 42.45 M | 31.21 M | — | 21.27 M | 16.57 M | 10.91 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
